1[1] Harris HL, Jaffe ES, Stein H et al. A revised European-American classification of lymphoid neoplasms: A proposal from the international lymphoma study group [J]. Blood, 1994; 84:1361-1392.
2[2] Jaffe ES, Harris HL, Chan JKC et al. Proposed World Health Organization classification of neoplastic diseases of hematopoietic and lymphoid tissues [J]. Am J Surg Pathol, 1997;21:114-121.
3[3] Jaffe ES, Harris HL, Diebold J et al. World Health Organization classification of neoplastic diseases of hematopoietic and lymphoid tissues [J]. Am J Clin Pathol, 1999;111(Suppl 1):S8-S12.
4Lennert K.Lymphoma research today[J].第四军医大学学报,1995,16(3):161-163.
5[5] Jaffe ES, Krenacs L, Kumar S et al. Extranodal peripheral T-cell and NK-cell neoplasms [J]. Am J Clin Pathol, 1999;111(suppl.1):S46-S55.
6[6] A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma [J]. Blood, 1997;89:3909-3918.
7[7] Hiddemann W, Longo DL, Coiffier B et al. Lymphoma classificationThe gap between biology and clinical management is closing [J]. Blood, 1996; 88:4085-4089.
8[8] Harris NL, Jaffe ES, Diebold J et al. The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997 [J]. Histopathology, 2000; 36(11):69-87.
9[9] Bun ChadA, Frizzera G. Mediastinal large B-cell lymphoma vs classic Hodgkin lymphoma [J]. Am J Clin Pathol, 1999;112:155-158.
10[10] Baars JVV, De Jong D, Willemse EM et al. Diffuse large B-cell non-Hodgkin's lymphomas: The clinical relevance of histological subclassification [J]. Br J Cancer, 1999;11:1770-1776.
